| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1999PNAS...96.5025K |
| P356 | DOI | 10.1073/PNAS.96.9.5025 |
| P932 | PMC publication ID | 21810 |
| P698 | PubMed publication ID | 10220412 |
| P5875 | ResearchGate publication ID | 13078836 |
| P50 | author | David Ron | Q18195722 |
| P2093 | author name string | X Wang | |
| K J Turner | |||
| L J Fitz | |||
| Y Yin | |||
| K A Jacobs | |||
| M Kuroda | |||
| P Chung | |||
| J Sok | |||
| J W Giannotti | |||
| P Murtha-Riel | |||
| P2860 | cites work | Cytogenetic findings in liposarcoma correlate with histopathologic subtypes | Q44846709 |
| Versatile retroviral vectors for potential use in gene therapy | Q45867146 | ||
| Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints | Q60035789 | ||
| Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features | Q73721197 | ||
| Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 | ||
| Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma | Q24309359 | ||
| The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains | Q24319886 | ||
| Identification of novel stress-induced genes downstream of chop | Q24533261 | ||
| The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 | ||
| A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP | Q28240554 | ||
| Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells | Q28276215 | ||
| Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase | Q28280649 | ||
| Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins | Q28287408 | ||
| CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription | Q28287446 | ||
| Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS | Q28296815 | ||
| The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development | Q28513428 | ||
| Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element | Q28570085 | ||
| CHOP-Dependent stress-inducible expression of a novel form of carbonic anhydrase VI | Q28587564 | ||
| Impaired Energy Homeostasis in C/EBPα Knockout Mice | Q34662358 | ||
| Mechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system | Q34692919 | ||
| Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21). | Q34719993 | ||
| Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis | Q34722721 | ||
| Identifying differences in mRNA expression by representational difference analysis of cDNA | Q35004368 | ||
| Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. | Q35669591 | ||
| Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein | Q35763469 | ||
| Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). | Q36561426 | ||
| Regulation of the C/EBP-related gene gadd153 by glucose deprivation | Q36694493 | ||
| Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents | Q36761728 | ||
| CCAAT-enhancer binding protein: a component of a differentiation switch | Q37624411 | ||
| Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice | Q37696753 | ||
| GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. | Q38355295 | ||
| Packaging system for rapid production of murine leukemia virus vectors with variable tropism | Q40067097 | ||
| Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). | Q40789492 | ||
| Reciprocal regulation of adipogenesis by Myc and C/EBP alpha | Q41628463 | ||
| Alteration of proteoglycan metabolism during the differentiation of 3T3-L1 fibroblasts into adipocytes | Q41672410 | ||
| CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. | Q42801637 | ||
| Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins | Q42818320 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function | Q42829035 | ||
| Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysine | Q42834581 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myxoid liposarcoma | Q6949365 |
| P304 | page(s) | 5025-5030 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Induction of a secreted protein by the myxoid liposarcoma oncogene | |
| P478 | volume | 96 |
| Q42223420 | A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression |
| Q34952133 | Advances in the targeted therapy of liposarcoma |
| Q30459373 | Biochemical Properties and Biological Functions of FET Proteins |
| Q38338293 | Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas |
| Q36272048 | Detection of fusion genes in sarcomas using paraffin-embedded tissues |
| Q36332766 | Human synovial lubricin expresses sialyl Lewis x determinant and has L-selectin ligand activity |
| Q34662602 | Male sterility and enhanced radiation sensitivity in TLS(-/-) mice |
| Q37248204 | Organization of nuclear architecture during adipocyte differentiation |
| Q35746797 | PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms |
| Q28574873 | Serial analysis of gene expression in the rat striatum following methamphetamine administration |
| Q51842639 | TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas. |
| Q33999337 | The TET family of proteins: functions and roles in disease |
| Q34566943 | The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells |
| Q51372405 | Ultraviolet light (UVB and UVA) induces the damage-responsive transcription factor CHOP/gadd153 in murine and human epidermis: evidence for a mechanism specific to intact skin. |
Search more.